Nicaragua Pharmaceuticals & Healthcare Q4 2018
We hold a weak outlook for Nicaragua’s pharmaceutical and healthcare market. Proposed budget cuts will restrictpatient access to medicines and healthcare services, limiting growth opportunities for pharmaceutical companies operating in thecountry. Furthermore, the ongoing political crisis and heightened social unrest will exacerbate the risks associated with Nicaragua,further deterring multinational drugmakers from investing in what is already one of the least attractive markets in the region.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook